Skylands Capital LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 28.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 161,090 shares of the company’s stock after acquiring an additional 35,550 shares during the quarter. GE HealthCare Technologies accounts for approximately 1.5% of Skylands Capital LLC’s portfolio, making the stock its 15th largest holding. Skylands Capital LLC’s holdings in GE HealthCare Technologies were worth $11,466,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Laurel Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies during the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies in the 4th quarter worth about $27,000. Montag A & Associates Inc. increased its stake in GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after buying an additional 262 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.
GE HealthCare Technologies Stock Performance
NASDAQ GEHC opened at $65.76 on Friday. The company’s 50 day moving average is $64.51 and its 200-day moving average is $73.96. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm has a market cap of $29.91 billion, a P/E ratio of 15.73, a price-to-earnings-growth ratio of 1.79 and a beta of 0.74.
Analyst Upgrades and Downgrades
GEHC has been the subject of a number of research analyst reports. Royal Bank Of Canada assumed coverage on GE HealthCare Technologies in a research report on Tuesday. They set an “outperform” rating and a $80.00 price target for the company. Jefferies Financial Group lowered their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. BNP Paribas Exane reduced their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Rothschild & Co Redburn lowered their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Finally, UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their target price for the company from $75.00 to $69.00 in a research report on Thursday, May 21st. Ten investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.20.
Read Our Latest Research Report on GEHC
Insider Activity
In related news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares in the company, valued at $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Watkin Phoebe L. Yang acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the purchase, the director owned 13,702 shares in the company, valued at $863,363.02. This trade represents a 7.87% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by corporate insiders.
GE HealthCare Technologies Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Read More
- Five stocks we like better than GE HealthCare Technologies
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
